Promontory Therapeutics Funding: $74M Raised, Series A
Promontory Therapeutics is based in New York, New York. It has raised $74M in total funding. Latest round: Series A.
Promontory Therapeutics funding overview
Promontory Therapeutics is based in New York, New York. Promontory Therapeutics has raised $74M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2021. The round record for Promontory Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include private investors, family investment offices. 2 distinct backers are named across the disclosed rounds.
Promontory Therapeutics at a glance
Total raised
$74M
Latest round
Series A
Latest round date
December 2021
Headquarters
New York, New York
Notable investors
private investors, family investment offices
Frequently asked about Promontory Therapeutics funding
How much has Promontory Therapeutics raised?
Promontory Therapeutics has raised $74M in total disclosed funding across the rounds on record.
Who has invested in Promontory Therapeutics?
private investors, family investment offices are named among the investors backing Promontory Therapeutics.
What was the latest Promontory Therapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2021.
Where is Promontory Therapeutics based?
Promontory Therapeutics is based in New York, New York.
When did Promontory Therapeutics last raise?
The last disclosed Promontory Therapeutics round closed in December 2021 at Series A.
Promontory Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York below to benchmark round size and investor mix.
